vs
Celsius Holdings, Inc.（CELH）与奥驰亚（MO）财务数据对比。点击上方公司名可切换其他公司
奥驰亚的季度营收约是Celsius Holdings, Inc.的8.1倍（$5.8B vs $721.6M）。奥驰亚净利率更高（19.1% vs 3.4%，领先15.7%）。Celsius Holdings, Inc.同比增速更快（117.2% vs -2.1%）。奥驰亚自由现金流更多（$3.2B vs $-130.0M）。过去两年Celsius Holdings, Inc.的营收复合增速更高（42.4% vs 2.4%）
Celsius Holdings Inc.是美国功能饮品企业，旗下Celsius品牌主打健身饮料、能量饮品系列，产品主打健康定位，公司CEO曾表示这一差异化优势是品牌取得市场成功的核心原因。
奥驰亚集团是美国头部烟草企业，通过旗下子公司生产销售可燃烟草与口服类烟草相关产品，核心品牌包括万宝路香烟、Black & Mild雪茄及烟斗烟、哥本哈根、斯库尔等湿无烟烟草，以及on!口服尼古丁袋，产品主要供应批发商、分销商及大型零售客户。
CELH vs MO — 直观对比
营收规模更大
MO
是对方的8.1倍
$721.6M
营收增速更快
CELH
高出119.4%
-2.1%
净利率更高
MO
高出15.7%
3.4%
自由现金流更多
MO
多$3.3B
$-130.0M
两年增速更快
CELH
近两年复合增速
2.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $721.6M | $5.8B |
| 净利润 | $24.7M | $1.1B |
| 毛利率 | 47.4% | 62.1% |
| 营业利润率 | 3.6% | 28.2% |
| 净利率 | 3.4% | 19.1% |
| 营收同比 | 117.2% | -2.1% |
| 净利润同比 | 231.1% | -63.2% |
| 每股收益（稀释后） | $0.04 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CELHMO
| Q4 25 | $721.6M | $5.8B | ||
| Q3 25 | $725.1M | $6.1B | ||
| Q2 25 | $739.3M | $6.1B | ||
| Q1 25 | $329.3M | $5.3B | ||
| Q4 24 | $332.2M | $6.0B | ||
| Q3 24 | $265.7M | $6.3B | ||
| Q2 24 | $402.0M | $6.2B | ||
| Q1 24 | $355.7M | $5.6B |
净利润CELHMO
| Q4 25 | $24.7M | $1.1B | ||
| Q3 25 | $-61.0M | $2.4B | ||
| Q2 25 | $99.9M | $2.4B | ||
| Q1 25 | $44.4M | $1.1B | ||
| Q4 24 | $-18.9M | $3.0B | ||
| Q3 24 | $6.4M | $2.3B | ||
| Q2 24 | $79.8M | $3.8B | ||
| Q1 24 | $77.8M | $2.1B |
毛利率CELHMO
| Q4 25 | 47.4% | 62.1% | ||
| Q3 25 | 51.3% | 62.8% | ||
| Q2 25 | 51.5% | 63.1% | ||
| Q1 25 | 52.3% | 61.8% | ||
| Q4 24 | 50.2% | 60.3% | ||
| Q3 24 | 46.0% | 60.8% | ||
| Q2 24 | 52.0% | 59.2% | ||
| Q1 24 | 51.2% | 58.8% |
营业利润率CELHMO
| Q4 25 | 3.6% | 28.2% | ||
| Q3 25 | -11.0% | 53.2% | ||
| Q2 25 | 19.3% | 52.9% | ||
| Q1 25 | 15.8% | 34.0% | ||
| Q4 24 | -5.6% | 48.2% | ||
| Q3 24 | -1.2% | 50.4% | ||
| Q2 24 | 23.4% | 40.8% | ||
| Q1 24 | 23.4% | 48.0% |
净利率CELHMO
| Q4 25 | 3.4% | 19.1% | ||
| Q3 25 | -8.4% | 39.1% | ||
| Q2 25 | 13.5% | 39.0% | ||
| Q1 25 | 13.5% | 20.5% | ||
| Q4 24 | -5.7% | 50.9% | ||
| Q3 24 | 2.4% | 36.6% | ||
| Q2 24 | 19.8% | 61.2% | ||
| Q1 24 | 21.9% | 38.2% |
每股收益（稀释后）CELHMO
| Q4 25 | $0.04 | $0.67 | ||
| Q3 25 | $-0.27 | $1.41 | ||
| Q2 25 | $0.33 | $1.41 | ||
| Q1 25 | $0.15 | $0.63 | ||
| Q4 24 | $-0.10 | $1.78 | ||
| Q3 24 | $0.00 | $1.34 | ||
| Q2 24 | $0.28 | $2.21 | ||
| Q1 24 | $0.27 | $1.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $398.9M | $4.5B |
| 总债务越低越好 | $676.9M | $25.7B |
| 股东权益账面价值 | $1.2B | $-3.5B |
| 总资产 | $5.1B | $35.0B |
| 负债/权益比越低杠杆越低 | 0.57× | — |
8季度趋势，按日历期对齐
现金及短期投资CELHMO
| Q4 25 | $398.9M | $4.5B | ||
| Q3 25 | $806.0M | $3.5B | ||
| Q2 25 | $615.2M | $1.3B | ||
| Q1 25 | $977.3M | $4.7B | ||
| Q4 24 | $890.2M | $3.1B | ||
| Q3 24 | $903.7M | $1.9B | ||
| Q2 24 | $903.2M | $1.8B | ||
| Q1 24 | $879.5M | $3.6B |
总债务CELHMO
| Q4 25 | $676.9M | $25.7B | ||
| Q3 25 | $870.5M | $25.7B | ||
| Q2 25 | $871.9M | $24.7B | ||
| Q1 25 | — | $26.1B | ||
| Q4 24 | — | $24.9B | ||
| Q3 24 | — | $25.2B | ||
| Q2 24 | — | $25.0B | ||
| Q1 24 | — | $25.0B |
股东权益CELHMO
| Q4 25 | $1.2B | $-3.5B | ||
| Q3 25 | $1.2B | $-2.6B | ||
| Q2 25 | $1.3B | $-3.3B | ||
| Q1 25 | $443.1M | $-3.5B | ||
| Q4 24 | $399.9M | $-2.2B | ||
| Q3 24 | $423.6M | $-3.5B | ||
| Q2 24 | $415.8M | $-3.0B | ||
| Q1 24 | $338.2M | $-5.1B |
总资产CELHMO
| Q4 25 | $5.1B | $35.0B | ||
| Q3 25 | $5.3B | $35.0B | ||
| Q2 25 | $3.8B | $32.3B | ||
| Q1 25 | $1.9B | $35.8B | ||
| Q4 24 | $1.8B | $35.2B | ||
| Q3 24 | $1.7B | $34.2B | ||
| Q2 24 | $1.7B | $34.4B | ||
| Q1 24 | $1.6B | $36.5B |
负债/权益比CELHMO
| Q4 25 | 0.57× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-119.4M | $3.3B |
| 自由现金流经营现金流 - 资本支出 | $-130.0M | $3.2B |
| 自由现金流率自由现金流/营收 | -18.0% | 54.4% |
| 资本支出强度资本支出/营收 | 1.5% | 1.6% |
| 现金转化率经营现金流/净利润 | -4.83× | 2.93× |
| 过去12个月自由现金流最近4个季度 | $323.4M | $9.1B |
8季度趋势，按日历期对齐
经营现金流CELHMO
| Q4 25 | $-119.4M | $3.3B | ||
| Q3 25 | $331.8M | $3.1B | ||
| Q2 25 | $43.7M | $205.0M | ||
| Q1 25 | $103.4M | $2.7B | ||
| Q4 24 | $75.7M | $3.3B | ||
| Q3 24 | $12.9M | $2.6B | ||
| Q2 24 | $39.6M | $-75.0M | ||
| Q1 24 | $134.6M | $2.9B |
自由现金流CELHMO
| Q4 25 | $-130.0M | $3.2B | ||
| Q3 25 | $321.5M | $3.0B | ||
| Q2 25 | $35.5M | $173.0M | ||
| Q1 25 | $96.4M | $2.7B | ||
| Q4 24 | $70.3M | $3.3B | ||
| Q3 24 | $8.7M | $2.6B | ||
| Q2 24 | $30.4M | $-104.0M | ||
| Q1 24 | $130.1M | $2.8B |
自由现金流率CELHMO
| Q4 25 | -18.0% | 54.4% | ||
| Q3 25 | 44.3% | 50.1% | ||
| Q2 25 | 4.8% | 2.8% | ||
| Q1 25 | 29.3% | 51.0% | ||
| Q4 24 | 21.2% | 55.1% | ||
| Q3 24 | 3.3% | 41.2% | ||
| Q2 24 | 7.6% | -1.7% | ||
| Q1 24 | 36.6% | 51.0% |
资本支出强度CELHMO
| Q4 25 | 1.5% | 1.6% | ||
| Q3 25 | 1.4% | 0.9% | ||
| Q2 25 | 1.1% | 0.5% | ||
| Q1 25 | 2.1% | 0.7% | ||
| Q4 24 | 1.6% | 0.8% | ||
| Q3 24 | 1.6% | 0.5% | ||
| Q2 24 | 2.3% | 0.5% | ||
| Q1 24 | 1.3% | 0.6% |
现金转化率CELHMO
| Q4 25 | -4.83× | 2.93× | ||
| Q3 25 | — | 1.30× | ||
| Q2 25 | 0.44× | 0.09× | ||
| Q1 25 | 2.33× | 2.53× | ||
| Q4 24 | — | 1.10× | ||
| Q3 24 | 2.03× | 1.14× | ||
| Q2 24 | 0.50× | -0.02× | ||
| Q1 24 | 1.73× | 1.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CELH
暂无分部数据
MO
| Smokeable Products Segment | $5.1B | 88% |
| Oral Tobacco Segment | $706.0M | 12% |
